Corbus Pharmaceuticals Holdings Inc (OQ:CRBP)

Sector:  Healthcare Industry:  Biotechnology & Medical Research
 
See Regulatory Filings on SEC
Company Contact
Address: 500 River Ridge Drive
NORWOOD MA 02062
Tel: N/A
Website: https://www.corbuspharma.com
IR: See website
<
Key People
Yuval Cohen
Chief Executive Officer, Director
Sean F. Moran
Chief Financial Officer
Dominic Smethurst
Chief Medical Officer
Business Overview
N/A
Financial Overview
For the fiscal year ended 31 December 2023, Corbus Pharmaceuticals Holdings Inc revenues was not reported. Net loss increased 5% to $44.6M. Higher net loss reflects Research and development - Balancing va increase of 98% to $30.8M (expense), Interest income,Net increase of 37% to $2.9M (expense), FV/Uls Adjust on Derivatives for Hedging decrease from $97K (income) to $3K (expense).
Employees: 19 as of Dec 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $368.54M as of Dec 31, 2023
Annual revenue (TTM): $0.00M as of Dec 31, 2023
EBITDA (TTM): -$44.44M as of Dec 31, 2023
Net annual income (TTM): -$44.60M as of Dec 31, 2023
Free cash flow (TTM): -$36.10M as of Dec 31, 2023
Net Debt Last Fiscal Year: N/A
Shares outstanding: 10,493,108 as of Mar 8, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.